ArticleScientific reports2026
von Willebrand Factor fibers formed at pathological high shear provide a scaffold for α-synuclein binding and aggregation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
α-Synuclein (αSyn) is an intrinsically disordered protein whose misfolding and aggregation promotes various synucleinopathies. Potentially relevant to the biophysics of αSyn-dependent pathology as well as seed amplification assays, we tested fibrous von Willebrand factor (vWF-fibers) generated at high shear for its ability to capture αSyn and induce αSyn misfolding. EDTA-plasma was perfused through a post-impingement microfluidic device at a peak shear rate of ~ 20,000 s−1 to generate vWF-fibers. Monomeric αSyn was then perfused over the vWF-fibers. In other experiments, pre-formed αSyn aggregates were perfused over vWF-fibers. X-34, a β-sheet-specific fluorescent dye, was used to label β-sheet structures, including vWF. Alexafluor-488-conjugated MJFR-14-6-4-2, an alpha-synuclein aggregate antibody, was used to label aggregated αSyn. The microposts effectively generated vWF-fibers. When monomeric α-Syn was perfused over vWF fibers, MJFR-14-6-4-2 revealed strong fluorescence staining relative to buffer control. Pre-formed aggregates also bound vWF-fibers. Annexin V and CD63 staining indicated the presence of plasma-derived phosphatidylserine-positive puncta on vWF-fibers. FITC-conjugated α-Syn monomer localized significantly on the vWF-fibers. Pathological vWF-fibers and bound PS-positive vesicles act as a scaffold on which αSyn can bind, misfold and aggregate. Additionally, vWF-fibers can bind/entrap preformed aggregates of αSyn. This study suggests potential crosstalk between vWF hemorheology and synuclein localization.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.